Ken Griffin's position in Corcept Therapeutics is currently worth $1.89 Million. That's 0.00% of their equity portfolio (2263rd largest holding). The first Corcept Therapeutics trade was made in Q1 2014. Since then Ken Griffin bought shares 49 more times and sold shares on 42 occasions. The stake costed the investor $1.5 Million, netting the investor a gain of 26% so far.